Lifecore Biomedical is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March. At this time, Lifecore Biomedical's Cash And Short Term Investments are relatively stable compared to the past year. As of 02/26/2025, Non Current Liabilities Total is likely to grow to about 218.5 M, while Other Current Liabilities is likely to drop slightly above 14.2 M. Key indicators impacting Lifecore Biomedical's financial strength include:
The financial analysis of Lifecore Biomedical is a critical element in measuring its lifeblood. Investors should not minimize Lifecore Biomedical's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
The reason investors look at the income statement is to determine what Lifecore Biomedical's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Lifecore Biomedical's current stock value. Our valuation model uses many indicators to compare Lifecore Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lifecore Biomedical competition to find correlations between indicators driving Lifecore Biomedical's intrinsic value. More Info.
Lifecore Biomedical is rated fourth overall in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Lifecore Biomedical's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Lifecore Biomedical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Lifecore Biomedical Systematic Risk
Lifecore Biomedical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Lifecore Biomedical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Lifecore Biomedical correlated with the market. If Beta is less than 0 Lifecore Biomedical generally moves in the opposite direction as compared to the market. If Lifecore Biomedical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Lifecore Biomedical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Lifecore Biomedical is generally in the same direction as the market. If Beta > 1 Lifecore Biomedical moves generally in the same direction as, but more than the movement of the benchmark.
Lifecore Biomedical February 26, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Lifecore Biomedical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Lifecore Biomedical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lifecore Biomedical based on widely used predictive technical indicators. In general, we focus on analyzing Lifecore Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lifecore Biomedical's daily price indicators and compare them against related drivers.
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.